Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Image Index

View All
Additional Pharmacology Considerations for Cancer Drug Marketing Applications
Anaplastic Lymphoma Kinase (ALK) Fusion
Antifolate Mechanism of Action
Aromatase Inhibitors (AIs)
Available Antibody-drug Conjugates
B-Cell Receptor (BCR)-ABL Translocation and the Philadelphia Chromosome
Biosynthesis of and rogens and Other Steroid Hormones from Cholesterol
Cell Cycle and Temporarily Related Chromosome Cycle
Characterization and Selection of Biomarkers
Chemical Structures of Abiraterone and its Prodrug, Abiraterone Acetate
Chromatin Structure and Epigenetic Marks
Clinical Importance of Methylguanine Methyltransferase
Clinical Trials Life Cycle
Components of 90y-Ibritumomab Tiuxetan
Cytokine Toxicity Man
Development of Biomarkers Based on Their Intended Use
Effects of the Tumor Microenvironment on Pharmacodynamics
Elements of an Antibody-drug Conjugate (ADC)
Epigenetics Modifying Agents and the Mechanism of Action
Estrogen-Dependent Tumor Growth
Examples of Boronic Acid (Left, Bortezomib) and Epoxyketone (Right, Carfilzomib) Proteasome Inhibitors
Folic Acid Cycle as Relevant for Conversion of Deoxyuridine Monophosphate (dUMP)
Getting to the Recommended Phase 2 Dose (Rp2d)
A Description of Current Immunotherapeutic Approaches in Myeloma
An Example of an Antibody-drug Conjugate (Ado-Trastuzumab Emtansine) in Action
Anti-Pd-1 and Anti-Pd-L1 Immunotherapies Have Demonstrated Unprecedented Clinical Activity
Asparaginases, as Amidohydrolases, Possess Both Asparaginase and Glutaminase Activity
Basic and Translation Approach to Clinical Trials
Biomarkers in Clinical Trials
CDK4/CDK6 and mTOR Signaling Pathways